From the MS Trust Website:
18 April 2010 - MedPage Today
Targeting B cells implicated in progressive multiple sclerosis with rituximab (Rituxan) therapy might help patients diagnosed with the disease, according to data from a small study reported here [annual meeting of the American Academy of Neurology].
"This study shows that rituximab could be an effective treatment in a subgroup of patients with secondary progressive multiple sclerosis," Carolina Ionete, MD, of the University of Massachusetts Medical School in Worcester, wrote in a poster presentation abstract for the annual meeting of the American Academy of Neurology.
Click here for more http://www.mstrust.org.uk/news/recentstories/article.jsp?id=3655